ViaNautis Bio
Pre-clinicalViaNautis is transforming cell and gene therapy with polyNaut® nanovesicles (PNVs), a modular, non-viral delivery system that enables precise, plug-and-play tar
Founded
2021
Focus
Drug DeliveryNanotechnology
About
ViaNautis is transforming cell and gene therapy with polyNaut® nanovesicles (PNVs), a modular, non-viral delivery system that enables precise, plug-and-play tar
Funding History
2Total raised: $28.2M
Series A$25MOctopus VenturesFeb 15, 2023
Seed$3.2MUndisclosedMay 15, 2021
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile